FlotteTR, AfioneSA, ConradC, et al.Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci U S A, 1993; 90:10613–10617.
2.
ConradCK, AllenSS, AfioneSA, et al.Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther, 1996; 3:658–668.
3.
BeckSE, JonesLA, ChesnutK, et al.Repeated delivery of adeno-associated virus vectors to the rabbit airway. J Virol, 1999; 73:9446–9455.
4.
MossRB, MillaC, ColomboJ, et al.Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial. Hum Gene Ther, 2007; 18:726–732.
5.
MingozziF, MausMV, HuiDJ, et al.CD8(+) T-cell responses to adeno-associated virus capsid in humans. Nat Med, 2007; 13:419–422.
6.
NathwaniAC, TuddenhamEG, RangarajanS, et al.Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med, 2011; 365:2357–2365.
CortiM, LiberatiC, SmithBK, et al.Safety of intradiaphragmatic delivery of adeno-associated virus-mediated alpha-glucosidase (rAAV1-CMV-hGAA) gene therapy in children affected by Pompe disease. Hum Gene Ther Clin Dev, 2017; 28:208–218.
9.
HindererC, KatzN, BuzaEL, et al.Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum Gene Ther, 2018; 29:285–298.
10.
HordeauxJ, HindererC, GoodeT, et al.Toxicology study of intra-cisterna magna adeno-associated virus 9 expressing human alpha-L-iduronidase in rhesus macaques. Mol Ther Methods Clin Dev, 2018; 10:79–88.
11.
HordeauxJ, HindererC, GoodeT, et al.Toxicology study of intra-cisterna magna adeno-associated virus 9 expressing iduronate-2-sulfatase in rhesus macaques. Mol Ther Methods Clin Dev, 2018; 10:68–78.
12.
PerezBA, ShutterlyA, ChanYK, et al.Management of neuroinflammatory responses to AAV-mediated gene therapies for neurodegenerative diseases. Brain Sci, 2020; 10.
